This mitigation of Αβ-induced pathology was attributed to miR-885-5p binding and reducing transcript levels of KREMEN1, a gene previously implicated in AD via noncoding RNA interactions (Wang et al., 2019). The gene discussed is KREMEN1; the disease is Alzheimer disease.